Allermi offers direct delivery of customized prescription allergy medications, designed and formulated by world-class allergists.
Allermi's investors include Shane Neman, Lucas Venture Group, Nelstone Ventures.
Allermi is headquartered in San Francisco, United States.
Allermi offers direct delivery of customized prescription allergy medications, designed and formulated by world-class allergists.
Allermi is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Allermi — Funding & Investors." VCBacked, April 1, 2024, https://www.vcbacked.co/company/allermi. Accessed October 30, 2026.
VCBacked. (2024). Allermi — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/allermi
{{cite web |title=Allermi — Funding & Investors |url=https://www.vcbacked.co/company/allermi |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated